In a significant advancement for brain-computer interface (BCI) technology, Neurable, a Boston-based neurotechnology firm, has successfully raised $13 million in a recent funding round. This injection of capital is aimed at accelerating the development and commercialization of Neurable’s groundbreaking BCI AI technology across various industries.

Transforming Neurotechnology

The funding round saw participation from several prominent venture capital firms including Ultratech Capital Partners, TRAC, Pace Ventures, and Metaplanet, highlighting the growing investor interest in innovative neurotechnologies. Since its inception, Neurable has raised over $30 million, demonstrating strong support for its vision to make BCI technology a staple in everyday products.

Funding Overview:

• Total Raised to Date: $30 million+
• Recent Funding: $13 million
• Key Investors: Ultratech Capital Partners, TRAC, Pace Ventures, Metaplanet

Neurable’s mission is to democratize access to advanced neurotechnology. The company plans to use the latest funds to expand its platform technology and scale its licensing business. This strategic move is expected to catalyze further development and experimentation in a variety of applications, making BCI technology more accessible to consumer audiences.

Strategic Objectives Post-Funding:

• Advance Platform Technology: Enhance the core technology for broader applications.
• Scale Licensing Business: Expand partnerships across multiple industries.
• Broaden Consumer Reach: Make non-invasive BCI technology widely available.

The company’s CEO, Ramses Alcaide, expressed his enthusiasm about the funding, stating, “This new round of funding underscores our commitment to making Neurable’s brain-computer interface technology accessible to everyone. We’re empowering individuals to understand their own mind, optimize human performance, and conquer the most pressing health challenges of our generation.”

Product and Platform Expansion

With the fresh capital, Neurable intends to continue expanding its platform, which provides companies and original equipment manufacturers (OEMs) access to its non-invasive BCI technology. This includes expanding its product portfolio, reference designs, algorithms, and enabled systems to encompass a wider range of products such as earbuds, helmets, and various head-worn devices designed to optimize human performance.

Key Products and Technologies:

• MW75 Neuro Headphones: AI-powered BCI-enabled headphones set to launch this summer.
• EEG AI Technology: Compact and powerful technology optimized for everyday use.
• Enabled Systems: Expansion to include earbuds, helmets, and other head-worn devices.

Dale Davis, a senior principal at Ultratech Capital Partners, emphasized the potential of Neurable’s technology, remarking, “Neurable’s transformative neurotechnology is at the forefront of the BCI revolution. BCI technology has gained significant momentum over the years, and its advancement shows no signs of slowing down. Neurable’s BCI has the potential to solve a range of vexing issues — from healthcare to daily life. BCI integrated into our devices, and a critical part of our everyday experience was once the stuff of science fiction — thanks to Neurable, that dream will soon be a reality.”

Collaborative Efforts and Future Aspirations

Founded as a University of Michigan spinout, Neurable has continually sought to collaborate with leading entities in both the private and public sectors. Following its Series A funding in 2020, Neurable partnered with consumer wearable companies, including headphone company Master & Dynamic, to embed EEG sensors into everyday technologies.

The partnership is set to introduce the first-ever BCI-enabled headphones, the MW75 Neuro, marking a significant milestone in consumer-accessible neurotechnology. Additionally, following Series A, Neurable collaborated with the Air Force Research Lab’s 711 Human-Performance Wing to validate and refine its technology for enhancing human performance.

Building on this successful collaboration, Neurable secured $5 million in contracts from the Department of Defense to further develop this cutting-edge human technology to support soldier health and performance.

Adam Molnar, cofounder and vice president of strategic partnerships at Neurable, shared his excitement about the partnerships, stating, “We’re extremely proud to work with our partners, which include some of the world’s best in consumer technology like Master & Dynamic as well as the very servicemen and women who make sacrifices on a daily basis for the overall security of our nation. This is just the beginning. We can’t wait to show you what’s coming next.”

As Neurable continues to push the boundaries of what is possible with neurotechnology, its recent funding round not only validates its past achievements but also sets the stage for an exciting future of innovation and widespread application of BCI technology.